scispace - formally typeset
X

Xiao-Long Chen

Researcher at Sichuan University

Publications -  100
Citations -  1889

Xiao-Long Chen is an academic researcher from Sichuan University. The author has contributed to research in topics: Cancer & Gastrectomy. The author has an hindex of 21, co-authored 90 publications receiving 1224 citations. Previous affiliations of Xiao-Long Chen include St. Jude Children's Research Hospital & Tongji University.

Papers
More filters
Journal ArticleDOI

Changes of Esophagogastric Junctional Adenocarcinoma and Gastroesophageal Reflux Disease Among Surgical Patients During 1988-2012: A Single-institution, High-volume Experience in China.

TL;DR: An increasing trend of EGJA is observed during the past 25 years in West China Hospital, and total gastrectomy is becoming more preferred procedure in patients with EGJA.
Journal ArticleDOI

Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer

TL;DR: High TCD68+/SCD68+ ratio and TCD8+/TFoxp3+ ratio were associated with improved overall survival, whereas high density of TFoxp 3+ cells and T CD66b+/ SCD66b- ratio demonstrated poor Overall survival, which are promising independent predictors for overall survival in gastric cancer.
Journal ArticleDOI

Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study

TL;DR: It is suggested that HALP was closely associated with clinicopathological features and was an independent prognostic factor in GC patients and Nomogram based on HALP could accurately predict the prognosis of GC patients.
Journal ArticleDOI

The Impact of Body Mass Index on the Surgical Outcomes of Patients With Gastric Cancer: A 10-Year, Single-Institution Cohort Study

TL;DR: Findings confirm the “obesity paradox” in GC patients undergoing gastrectomy, where a low BMI was associated with more severe postoperative complications and poorer prognosis and the high-BMI patients exhibited paradoxically “superior” survival outcomes compared with the normal-B MI patients.